Hager I Allam, M. H. Sabra, Khaled E Elrabbat, Abd El-Moneum
{"title":"Cardiac MRI Findings in Symptomatic Post Covid Patients with Suspected Myocarditis","authors":"Hager I Allam, M. H. Sabra, Khaled E Elrabbat, Abd El-Moneum","doi":"10.21608/ejhm.2024.344772","DOIUrl":null,"url":null,"abstract":"Background: Cardiovascular magnetic resonance (CMR) imaging, considered the gold standard for myocarditis diagnosis, presented conflicting results on the prevalence of COVID-19-associated myocarditis. Objective: This study aimed to describe CMR findings in patients with active COVID-19 infection within three months of infection and who had suspected acute myocarditis. Patients and Methods: This was a multi-center cross-sectional study that comprised adult patients with COVID-19 and clinical suspicion of associated myocarditis. Evaluation encompassed history, clinical examination, laboratory investigations, ECG, echocardiography, and CMR using the revised Lake Louise Criteria 2018 for myocarditis diagnosis. Participants (n=100) were divided into three groups based on CMR findings (Group I (n = 6); no myocarditis, Group II (n = 63); suspected myocarditis, and Group III; proved myocarditis. Notably, Group III (n = 31) exhibited distinct characteristics. Results: A multivariate analysis showed that chest pain, ferritin levels, and LAVI significantly predicted proved myocarditis after adjusting the other confounding factors. Conclusions: Active COVID-19 infection within three months showed a high prevalence of suspected and proved myocarditis, with specific characteristics in the proved myocarditis group.","PeriodicalId":22467,"journal":{"name":"The Egyptian Journal of Hospital Medicine","volume":"14 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Hospital Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ejhm.2024.344772","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cardiovascular magnetic resonance (CMR) imaging, considered the gold standard for myocarditis diagnosis, presented conflicting results on the prevalence of COVID-19-associated myocarditis. Objective: This study aimed to describe CMR findings in patients with active COVID-19 infection within three months of infection and who had suspected acute myocarditis. Patients and Methods: This was a multi-center cross-sectional study that comprised adult patients with COVID-19 and clinical suspicion of associated myocarditis. Evaluation encompassed history, clinical examination, laboratory investigations, ECG, echocardiography, and CMR using the revised Lake Louise Criteria 2018 for myocarditis diagnosis. Participants (n=100) were divided into three groups based on CMR findings (Group I (n = 6); no myocarditis, Group II (n = 63); suspected myocarditis, and Group III; proved myocarditis. Notably, Group III (n = 31) exhibited distinct characteristics. Results: A multivariate analysis showed that chest pain, ferritin levels, and LAVI significantly predicted proved myocarditis after adjusting the other confounding factors. Conclusions: Active COVID-19 infection within three months showed a high prevalence of suspected and proved myocarditis, with specific characteristics in the proved myocarditis group.